222 related articles for article (PubMed ID: 29316826)
1. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
[TBL] [Abstract][Full Text] [Related]
2. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections.
Nickler M; Ottiger M; Steuer C; Huber A; Anderson JB; Müller B; Schuetz P
Respir Res; 2015 Oct; 16():125. PubMed ID: 26471192
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profile of children with recurrent respiratory infections.
Bozzetto S; Pirillo P; Carraro S; Berardi M; Cesca L; Stocchero M; Giordano G; Zanconato S; Baraldi E
Pharmacol Res; 2017 Jan; 115():162-167. PubMed ID: 27888158
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic findings in sepsis as a damage of host-microbial metabolism integration.
Beloborodova NV; Olenin AY; Pautova AK
J Crit Care; 2018 Feb; 43():246-255. PubMed ID: 28942199
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic changes in vertebrate host during malaria disease progression.
Ghosh S; Pathak S; Sonawat HM; Sharma S; Sengupta A
Cytokine; 2018 Dec; 112():32-43. PubMed ID: 30057363
[TBL] [Abstract][Full Text] [Related]
6. Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment.
Omabe M; Elom S; Omabe KN
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):221-229. PubMed ID: 29359679
[TBL] [Abstract][Full Text] [Related]
7. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review.
Ke C; Pan CW; Zhang Y; Zhu X; Zhang Y
Metabolomics; 2019 Nov; 15(12):152. PubMed ID: 31754808
[TBL] [Abstract][Full Text] [Related]
9. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
10. Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation.
Wang J; Sun Y; Teng S; Li K
BMC Med; 2020 Apr; 18(1):83. PubMed ID: 32290837
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():75-81. PubMed ID: 25575172
[TBL] [Abstract][Full Text] [Related]
12. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
13. Uncovering the metabolomic fingerprint of breast cancer.
Oakman C; Tenori L; Biganzoli L; Santarpia L; Cappadona S; Luchinat C; Di Leo A
Int J Biochem Cell Biol; 2011 Jul; 43(7):1010-20. PubMed ID: 20460168
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics in infectious diseases and drug discovery.
Tounta V; Liu Y; Cheyne A; Larrouy-Maumus G
Mol Omics; 2021 Jun; 17(3):376-393. PubMed ID: 34125125
[TBL] [Abstract][Full Text] [Related]
15. The metabolomic signature of hematologic malignancies.
Allegra A; Innao V; Gerace D; Bianco O; Musolino C
Leuk Res; 2016 Oct; 49():22-35. PubMed ID: 27526405
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis.
Englert JA; Rogers AJ
Clin Chest Med; 2016 Jun; 37(2):321-31. PubMed ID: 27229648
[TBL] [Abstract][Full Text] [Related]
17. Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection.
Neugebauer S; Giamarellos-Bourboulis EJ; Pelekanou A; Marioli A; Baziaka F; Tsangaris I; Bauer M; Kiehntopf M
Crit Care Med; 2016 Sep; 44(9):1649-62. PubMed ID: 27097292
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic analysis as biomarker to study steroid hormone administration in sepsis.
Lehmann C; Sharawy N; Zhou J; Pavlovic D
Med Hypotheses; 2012 Sep; 79(3):329-30. PubMed ID: 22658360
[TBL] [Abstract][Full Text] [Related]
19. Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Dietrich S; Floegel A; Weikert C; Prehn C; Adamski J; Pischon T; Boeing H; Drogan D
Hypertension; 2016 Aug; 68(2):471-7. PubMed ID: 27245178
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
